The First Class of Small Molecules Potently Disrupting the YAP-TEAD Interaction by Direct Competition.


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
06 10 2022
Historique:
revised: 10 08 2022
received: 01 06 2022
pubmed: 12 8 2022
medline: 12 10 2022
entrez: 11 8 2022
Statut: ppublish

Résumé

Inhibition of the YAP-TEAD protein-protein interaction is an attractive therapeutic concept under intense investigation with the objective to treat cancers associated with a dysregulation of the Hippo pathway. However, owing to the very extended surface of interaction of the two proteins, the identification of small drug-like molecules able to efficiently prevent YAP from binding to TEAD by direct competition has been elusive so far. We disclose here the discovery of the first class of small molecules potently inhibiting the YAP-TEAD interaction by binding at one of the main interaction sites of YAP at the surface of TEAD. These inhibitors, providing a path forward to pharmacological intervention in the Hippo pathway, evolved from a weakly active virtual screening hit advanced to high potency by structure-based design.

Identifiants

pubmed: 35950546
doi: 10.1002/cmdc.202200303
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Transcription Factors 0
YAP-Signaling Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202200303

Informations de copyright

© 2022 Wiley-VCH GmbH.

Références

S. Ma, Z. Meng, R. Chen, K. L. Guan, Annu. Rev. Biochem. 2019, 88, 577-604.
S. Piccolo, S. Dupont, M. Cordenonsi, Physiol. Rev. 2014, 94, 1287-1312.
G. Halder, R. L. Johnson, Development 2011, 138, 9-22.
A. V. Pobbati, W. Hong, Theranostics 2020, 10, 3622-3635.
H. D. Huh, D. H. Kim, H−S. Jeong, H. W. Park, Cells 2019, 8, 600.
M. Santucci, T. Vignutelli, S. Ferrari, M. Mor, L. Scalvini, M. L. Bolognesi, E. Uliassi, M. P. Costi, J. Med. Chem. 2015, 58, 4857-4873.
A. V. Pobbati, B. P. Rubin, Molecules 2020, 25, 6001.
J. J. Crawford, S. M. Bronner, J. R. Zbieg, Expert Opin. Ther. Pat. 2018, 28, 867-873.
S. Kakiuchi-Kiyota, M. M. Schutten, Y. Zhong, J. J. Crawford, A. Dey, Front. Cell Dev. Biol. 2019, 7, 156.
L. Chen, S. W. Chan, X. Zhang, M. Walsh, C. J. Lim, W. Hong, H. Song, Genes Dev. 2010, 24, 290.
Z. Li, B. Zhao, P. Wang, F. Chen, Z. Dong, H. Yang, K−L. Guan, Y. Xu, Genes Dev. 2010, 24, 235.
P. Furet, B. Salem, Y. Mesrouze, T. Schmelzle, I. Lewis, J. Kallen, P. Chène, Bioorg. Med. Chem. Lett. 2019, 29, 2316-2319.
M. Sturbaut, F. Bailly, M. Coevoet, P. Sileo, M. Pugniere, M. Liberelle, R. Magnez, X. Thuru, M−C. Chartier-Harlin, P. Melnyk, M. Gelin, F. Allemand, J−F. Guichou, P. Cotelle, Eur. J. Med. Chem. 2021, 226, 113835.
F. Gibault, M. Sturbaut, M. Coevoet, M. Pugniere, A. Burtscher, F. Allemand, P. Melnyk, W. Hong, B. P. Rubin, A. V. Pobbati, J−F. Guichou, P. Cotelle, F. Bailly, ChemMedChem 2021, 16, 2823-2844.
J. Kim, H. Lim, S. Moon, S. Y. Cho, M. Kim, J. H. Park, H. W. Park, K. T. No, Cancers 2021, 13, 4246.
S. A. Smith, R. B. Sessions, D. K. Shoemark, C. Williams, R. Ebrahimighaei, M. C. McNeill, M. P. Crump, T. R. McKay, G. Harris, A. C. Newby, M. Bond, J. Med. Chem. 2019, 62, 1291-1305.
C. L. Noland, S. Gierke, P. D. Schnier, J. Murray, W. N. Sandoval, M. Sagolla, A. Dey, R. N. Hannoush, W. J. Fairbrother, C. N. Cunningham, Structure 2016, 24, 179-186.
E. R. Barry, V. Simov, I. Valtingoyer, O. Venier, Cells 2021, 10, 2715.
L. Mélin, S. Abdullayev, A. Fnaiche, V. Vu, N. González Suárez, H. Zeng, M. M. Szewczyk, F. Li, G. Senisterra, A. Allali-Hassani, I. Chau, A. Dong, S. Woo, B. Annabi, L. Halabelian, S. R. LaPlante, M. Vedadi, D. Barsyte-Lovejoy, V. Santhakumar, A. Gagnon, ChemMedChem 2021, 16, 2982-3002.
J. K. Holden, J. J. Crawford, C. L. Noland, S. Schmidt, J. R. Zbieg, J. A. Lacap, R. Zang, G. M. Miller, Y. Zhang, P. Beroza, R. Reja, W. Lee, J. Y. K. Tom, R. Fong, M. Staffek, S. Clausen, T. J. Hagenbeek, T. Hu, Z. Zhou, H. C. Shen, C. N. Cunningham, Cell Rep. 2020, 31, 107809.
K. Bum-Erdene, D. Zhou, H. Gonzalez-Gutierrez, M. K. Ghozayel, Y. Si, D. Xu, H. E. Shannon, B. J. Bailey, T. W. Corson, K. E. Pollok, C. D. Wells, S. O. Meroueh, Cell Chem. Biol. 2019, 26, 378-389.
A. Kaneda, T. Seike, T. Danjo, T. Nakajima, N. Otsubo, D. Yamaguchi, Y. Tsuji, K. Hamaguchi, M. Yasunaga, Y. Nishiya, M. Suzuki, J−I. Saito, R. Yatsunami, S. Nakamura, Y. Sekido, K. Mori, Am. J. Cancer Res. 2020, 10, 4399-4415.
W. Lu, J. Wang, Y. Li, H. Tao, H. Xiong, F. Lian, J. Gao, H. Ma, T. Lu, D. Zhang, X. Ye, H. Ding, L. Yue, Y. Zhang, H. Tang, N. Zhang, Y. Yang, H. Jiang, K. Chen, B. Zhou, C. Luo, Eur. J. Med. Chem. 2019, 184, 111767.
A. V. Pobbati, T. Mejuch, S. Chakrabarty, H. Karatas, S. R. Bharath, S. M. Guéret, P−A. Goy, G. Hahne, A. Pahl, S. Sievers, E. Guccione, H. Song, H. Waldmann, W. Hong, ACS Chem. Biol. 2019, 14, 2909-2921.
J. C. Hau, D. Erdmann, Y. Mesrouze, P. Furet, P. Fontana, C. Zimmermann, T. Schmelzle, F. Hofmann, P. Chène, ChemBioChem. 2013, 14, 1218.
R. A. Friesner, J. L. Banks, R. B. Murphy, T. A. Halgren, J. J. Klicic, D. T. Mainz, M. P. Repasky, E. H. Knoll, D. E. Shaw, M. Shelley, J. K. Perry, P. Francis, P. S. Shenkin, J. Med. Chem. 2004, 47, 1739-1749. (Schrödinger, Inc.).
L. Fielding, Prog. Nucl. Magn. Reson. Spectrosc. 2007, 51, 219-242.
K. Inomata, A. Abe, J. Phys. Chem. 1992, 96, 7934-7937.
F. Bokhovchuk, Y. Mesrouze, C. Delaunay, T. Martin, F. Villard, M. Meyerhofer, P. Fontana, C. Zimmermann, D. Erdmann, P. Furet, C. Scheufler, T. Schmelzle, P. Chène, Protein Sci. 2020, 29, 509-520.
W. Tian, J. Yu, D. R. Tomchick, D. Pan, X. Luo, Proc. Natl. Acad. Sci. USA 2010, 107, 7293-7298.
Y. Mesrouze, F. Bokhovchuk, A. Izaac, M. Meyerhofer, C. Zimmermann, P. Fontana, T. Schmelzle, D. Erdmann, P. Furet, J. Kallen, P. Chène, Protein Sci. 2018, 27, 1810-1820.
Novartis. Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors. WO2021186324; 2021.
C. Vonrhein, C. Flensburg, P. Keller, A. Sharff, O. Smart, W. Paciorek, T. Womack, G. Bricogne, Acta Crystallogr. 2011, D67, 293-302.
I. J.Tickle, C. Flensburg, P. Keller, W. Paciorek, A. Sharff, C. Vonrhein, G. Bricogne, 2018,. STARANISO. Cambridge, United Kingdom: Global Phasing Ltd.
A. J. McCoy, R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni, R. J. Read, J. Appl. Crystallogr. 2007, 40 (Pt 4),658-674.
P. Emsley, K. Cowtan, Acta Crystallogr. 2004, D60, 2126-2132.
G. Bricogne, E. Blanc, M. Brandl, C. Flensburg, P. Keller, W. Paciorek, P. Roversi, A. Sharff, O. S. Smart, C. Vonrhein, T. O. Womack, 2017,. BUSTER version 2.11.8. Cambridge, United Kingdom: Global Phasing Ltd.

Auteurs

Pascal Furet (P)

Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Vincent Bordas (V)

Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Mickaël Le Douget (M)

Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Bahaa Salem (B)

Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Yannick Mesrouze (Y)

Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Patricia Imbach-Weese (P)

Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Holger Sellner (H)

Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Markus Voegtle (M)

Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Nicolas Soldermann (N)

Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Emilie Chapeau (E)

Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Markus Wartmann (M)

Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Clemens Scheufler (C)

Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Cesar Fernandez (C)

Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Joerg Kallen (J)

Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Vito Guagnano (V)

Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Patrick Chène (P)

Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Tobias Schmelzle (T)

Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH